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Abstract
Background: A close correlation between celiac disease (CD) and oral lesions has been reported.
The aim of this case-control study was to assess prevalence of enamel hypoplasia, recurrent
aphthous stomatitis (RAS), dermatitis herpetiformis and atrophic glossitis in an Italian cohort of
patients with CD.
Methods: Fifty patients with CD and fifty healthy subjects (age range: 3–25 years), matched for
age, gender and geographical area, were evaluated by a single trained examiner. Diagnosis of oral
diseases was based on typical medical history and clinical features. Histopathological analysis was
performed when needed. Adequate univariate statistical analysis was performed.
Results: Enamel hypoplasia was observed in 26% cases vs 16% in controls (p > 0.2; OR = 1.8446;
95% CI = 0.6886: 4.9414). Frequency of RAS in the CD group was significantly higher (36% vs 12%;
p = 0.0091; OR = 4.125; 95% CI = 1.4725: 11.552) in CD group than that in controls (36% vs 12%).
Four cases of atrophic glossitis and 1 of dermatitis herpetiformis were found in CD patients vs 1
and none, respectively, among controls.
Conclusion: The prevalence of enamel hypoplasia was not higher in the study population than in
the control group. RAS was significantly more frequent in patients with CD.
Background
Celiac disease (CD), also known as celiac sprue or gluten-
sensitive entheropathy, can be defined as a chronic
inflammatory intestinal disease characterised by nutrient
malabsorption and improvement after the withdrawal of
gluten (found in wheat, barley) from the diet. Prevalence
of CD ranges from 1:85 to 1:300 have been reported for
CD in Western countries [1-6]. In addition to the classical
gastrointestinal presentation (diarrhoea, abdominal dis-
tension, vomiting, weight loss and pallor) CD can cause
minimal intestinal damage and weak or absent systemic
symptomatology (also known as "silent form"). In these
patients the lack of symptoms can persist for a long time,
while the biopsy of the bowel shows the typical atrophy
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of intestinal mucosa [7]. It is also well recognized the
association of CD with several complications, as lympho-
mas, autoimmune and degenerative nervous system dis-
eases [8-10].
The oral cavity, a part of gastrointestinal system [11], can
also be affected by several abnormalities in patients with
CD. As the mouth is very easy to examine, oral lesions can
provide a valuable clinical clue for early diagnosis of CD
[12]; in fact among the atypical aspects of CD (extra-intes-
tinals), in the international literature has been reported
some affections interesting the oral cavity, the most com-
mon are recurrent aphthous stomatitis (RAS) [13-15] and
dental enamel defects [8,13,16-21], in addition have been
described the association between CD and unspecific
forms of atrophic glossitis [22], oral manifestations of
dermatitis herpetiformis [23], Sjögren's syndrome [24,25]
and oral lichen planus [26,27]. These disorders, in
absence of a typical intestinal symptomatology, can repre-
sent useful clues for a timely diagnosis [7,22].
However, data from literature are often controversial,
probably because of different geographical origin of
patients studied and lack of adequate controls. Finally, no
studies have been performed, in CD patients of a Central
Region of Italy (Ancona, Marche, Italy)
The aim of this case-control study was to assess prevalence
of dental hard and oral soft tissues changes generally con-
sidered celiac-related (e.g. RAS, enamel hypoplasia, der-
matitis herpetiformis and atrophic glossitis) and to verify
if cases are more likely to be affected by any of the oral dis-
eases considered.
Methods
Fifty CD patients, aged between 3 and 18 years old and
living in the Region of Marche, were enrolled in the study.
CD was diagnosed at Paediatric Department of the Uni-
versity Politecnica of Marche (Ancona, Italy), and the
diagnosis of CD was based on serological tests (Ab-htTG
IgA, Ab-htTG IgG, AGA IgA, AGA IgG, EMA IgA, EMA
IgG), small-bowel biopsy during esophago-gastro-duode-
noscopy (EGDS) and histological evidence of villous atro-
phy with crypt hyperplasia and increase in intraepithelial
lymphocytes (normal, 10–30 per 100 epithelial cells),
and the disappearance of the symptoms and normaliza-
tion of serum anti-tTG and/or EMA after gluten-free-diet
(GFD) [28,29]. The control group was recruited by simple
randomization at a Primary and Secondary Public School
of Ancona, during an healthy prevention programme for
oral disease, matched one-to-one and without any signif-
icant differences with study group for geographical area,
age and gender (p > 0.2 by t-Student and chi-square test,
respectively). These young individuals neither reported
any gastrointestinal diseases and not have a family history
of CD.
Patients were examined for hard tissue changes (i.e. dental
enamel defects) and soft tissue lesions (RAS, dermatitis
herpetiformis and atrophic glossitis). Patients with CD
and healthy individuals were examined by a single
observer. Informed consent was obtained by parents who
were also asked about previous episodes of RAS affecting
child/children.
The enamel defects affecting deciduous and permanent
teeth were graded 0 to IV according to Aine's classification
[17] with a special attention to symmetric anomalies.
Soft tissues examination was carried out with conven-
tional dental chairs, artificial light, flat mirrors, monouse
probe and sterile gauzes.
With regard RAS, we registered both lesions clinically
observed and ulcerative events referred by parents or
reported by hospital clinical records. They were classified
into minor, major and herpetic aphthous ulcers [30],
according to dimension, form, localization and evolu-
tionary tendency, and also rate of occurrence was regis-
tered. Atrophic glossitis was diagnosed on the basis of
clinical features and oral mucosal lesions due to dermati-
tis herpetiformis were assessed by both clinical features
and histological/immunofluorescence studies.
Statistical analysis
Data were analyzed by means of StaView for Windows
(SAS Inc v. 5.0.1, Cary, NC, USA). To measure the associ-
ation level, Odds Ratio (OR) and the 95% corresponding
test-based Confidence Interval (CI) were calculated. T-Stu-
dent test was used to calculate significant differences
between cases and controls at baseline for ordinal varia-
bles. Chi-square test was used to assess statistical differ-
ences among categorical variables. In all of evaluations p-
values = 0.05 were considered statistically significant.
Results
Enamel alterations were observed in 13/50 (26%) sub-
jects with CD and in 8/50 (16%) controls, with a ratio
male-female of 1:2 for the celiac group and 2:1 for control
group (p > 0.2; OR = 1.8446; 95% CI = 0.6886: 4.9414).
With respect to the severity score of hypoplasia, 10/13 CD
patients showed lesions of degree 1 and 3/13 degree 2, in
controls all were in degree 1. The grade 1 enamel defects
were generally localized on incisor surfaces (for the ante-
rior sectors) (Figure 1) and cuspid surfaces (for the poste-
rior sectors), with dimensions from 1 to 3 mm and with a
round-oval form, while that of grade 2 were on the canine
and premolar vestibular surface. The colour alterationsHead & Face Medicine 2007, 3:25 http://www.head-face-med.com/content/3/1/25
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were white-yellowish, with clear margins, opaque and
smooth surface.
Episodes of RAS occurred in 36% of CD patients (18/50)
vs 12% of controls (6/50) (p = 0.0091; OR = 4.125; 95%
CI = 1.4725: 11.552) with a male-female ratio of 1:1 and
2:3, respectively (Figure 2). In CD patients RAS showed
greater rate of recurrence than in controls. Atrophic glossi-
tis was reported in 4 cases and one control, and dermatitis
herpetiformis in one patient with CD and none of sub-
jects without CD.
Discussion and conclusion
Recent epidemiology data showed the prevalence of CD
to approach 1% of the general population [31-34]. How-
ever, the clinical presentation of CD seems to differ from
the typical form observed in past years, as almost 50% of
the patients with newly diagnosed CD do not present with
gastrointestinal symptoms [35,36]. Thus, in order to iden-
tify the greatest number of "atypical" or "silent" CD
patients and prevent long-term complications, it has been
suggested that the clinicians should investigate those sub-
jects who present "indirect" signs of CD, such as chronic
anaemia [37], hyper-transaminasemia or hyperamy-
lasemia of unknown origin [38,39], osteoporosis [40],
autoimmune thyroid disorders [41].
As abnormalities of the oral cavity have been reported in
CD, non-invasive clinical examination of the oral cavity
can contribute to identify patients with atypical or silent
CD [13,14,17,18,42].
As regards to changes of dental tissues, we did not found
CD patients more likely to suffer from systematic and
symmetric enamel defects. Indeed, a wide range of fre-
quencies of enamel defects in CD patients has been
reported in other studies [17,43-48]; our data are in agree-
ment with other studies performed in Italy (Table 1) and
the high frequency of enamel defect found in controls, as
well as its severity, is likely to be related to environmental,
dietetic and genetic factors [46]. Further studies are war-
ranted to clarify the pathogenesis of this defect as nutri-
tional, immunologic or genetic factors (association with
the HLA DR3 allele) has been hypothesized [45,49]. With
regard to celiac patients, enamel defects have been corre-
lated to an altered phosphate-calcium metabolism and/or
formation of antibodies against the matrix of enamel
organ. The antigen correlated to class II molecules of the
MHC could prime an immunity movement against the
enamel organ, from which a mineralization disorder
could derive [18]. In addiction, there is no strong evidence
that these anomalies are correlated with the nutritional
status, vitamin D deficiency or to an excess of fluoride
incorporation. Current evidence suggests that an autoim-
mune pathogenesis is more likely, as enamel defects are
also present in autoimmune diseases, such as some poly-
endocrine syndromes [46].
With respect to oral soft lesions, we confirmed that CD
patients are likely to suffer from RAS compared with
healthy controls, especially before the gluten-free diet.
In our celiac population RAS was found in 26 % of CD
patients with an OR of 4.12 in comparison with the con-
trols. Even if a wide range of frequencies have been
reported (Table 2) our data show the highest prevalence
of RAS with respect to other Italian studies.
In agreement with Sedghizadeh et al. [14], we suggested to
consider RAS as a "risk indicator" of CD more than CD as
Several RAS on buccal mucosa in a CD patient Figure 2
Several RAS on buccal mucosa in a CD patient.
Symmetrical enamel hypoplasia of grade I on permanent inci- sors in a CD patient Figure 1
Symmetrical enamel hypoplasia of grade I on permanent inci-
sors in a CD patient.Head & Face Medicine 2007, 3:25 http://www.head-face-med.com/content/3/1/25
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a risk factor for RAS, although no definitive statement is
possible on their predictive role for CD.
In addition the term "recurrent aphthous stomatitis"
should be reserved to recurrent oral ulcer that present in
patients without systemic diseases, while ulcers that have
a clinical appearance similar to RAS, but found in patients
with systemic disorders (such as CD) should be termed
"aphthous-like ulcers" [50]. Even if the diagnostic criteria
of RAS used in this study (namely, medical history and/or
presence of detectable lesions) may represent a major lim-
itation of present research, it is well accepted that recur-
rent and episodic nature of oral ulcerations requires
medical history to be an important part of the diagnostic
process.
RAS is often associated to haematinic (iron, folate, vita-
min B12) deficiency [51,52]; since atypical or latent CD
may not manifest itself with gastrointestinal signs/symp-
toms but often with iron/folate deficiency [53-56] we sug-
gest that when patients show persistent RAS they should
be examined for haematinic deficiencies. Only if one or
more of these deficiencies are present, they should be
screened for CD.
In conclusion, our data from central Italy confirming the
higher prevalence of RAS or aphthous-like ulcers in
patients with CD validate the hypothesis of their pathoge-
netic predisposition to oral mucosal lesions more than
hard dental tissue lesions; further investigations are war-
ranted to clarify the predictive role of these lesions in
screening oligosymptomatic or asymptomatic CD.
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